Added to YB: 2026-06-17
Pitch date: 2026-03-31
EW [bullish]
Edwards Lifesciences Corporation
+9.36%
current return
Author Info
No bio for this author
Company Info
Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally.
Market Cap
$49.7B
Pitch Price
$81.00
Price Target
N/A
Dividend
N/A
EV/EBITDA
24.15
P/E
46.76
EV/Sales
7.41
Sector
Health Care Equipment and Supplies
Category
growth
Artisan U.S. Mid-Cap Growth Strategy Added On Portfolio Holding: Edwards Lifesciences Corporation
EW (added to position): Cardiovascular device leader in minimally invasive heart valves. Added as core aortic franchise reaccelerates & newer tricuspid valves drive rapid TAM expansion. Strong clinical data, rising physician adoption, share gains vs struggling competitors. Margin expansion ahead post-investment.
Read full article (1 min)